Promising Alzheimer’s Treatment: Blarcamesine’s Impact on Neurodegeneration
In a significant breakthrough for Alzheimer’s research, Anavex Life Sciences has revealed promising results from a comprehensive phase 2b/3 trial of their investigational therapy, blarcamesine. The study highlighted a notable. read more…
Continue Reading